Integrated Filing — IndAS



General information about company
Scrip Code 539148
NSE Symbol SHIVALIK
MSEI Symbol NA
ISIN INE788J01021
Name of company Shivalik Rasayan Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 21-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 30-May-2025   18:45:00
End date and time of board meeting 30-May-2025   20:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 693946000 3117731000
Other income 57102000 83067000
Total income 751048000 3200798000
2 Expenses
(a) Cost of materials consumed 289708000 1734489000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 38284000 -130379000
(d) Employee benefit expense 148328000 550218000
(e) Finance costs 27093000 93337000
(f) Depreciation, depletion and amortisation expense 27827000 157700000
(f) Other Expenses
1 Other Expenses 160047000 561358000
Total other expenses 160047000 561358000
Total expenses 691287000 2966723000
3 Total profit before exceptional items and tax 59761000 234075000
4 Exceptional items 0 0
5 Total profit before tax 59761000 234075000
6 Tax expense
7 Current tax 25392000 55030000
8 Deferred tax -17537000 -25181000
9 Total tax expenses 7855000 29849000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 51906000 204226000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 51906000 204226000
17 Other comprehensive income net of taxes 0 0
18 Total Comprehensive Income for the period 51906000 204226000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 41312000 166912000
Total profit or loss, attributable to non-controlling interests 10594000 37264000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0 0
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0 0
21 Details of equity share capital
Paid-up equity share capital 78752000 78752000
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.62 10.6
Diluted earnings (loss) per share from continuing operations 2.62 10.6
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.62 10.6
Diluted earnings (loss) per share from continuing and discontinued operations 2.62 10.6
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 3356555000
Capital work-in-progress
Investment property
Goodwill 0
Other intangible assets 7423000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 0
Trade receivables, non-current
Loans, non-current 25922000
Other non-current financial assets
Total non-current financial assets 25922000
Deferred tax assets (net) 65348000
Other non-current assets 711111000
Total non-current assets 4166359000
2 Current assets
Inventories 1177004000
Current financial asset
Current investments 0
Trade receivables, current 961159000
Cash and cash equivalents 279695000
Bank balance other than cash and cash equivalents 0
Loans, current 47932000
Other current financial assets 0
Total current financial assets 1288786000
Current tax assets (net) 0
Other current assets 708071000
Total current assets 3173861000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 7340220000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 78752000
Other equity 5280896000
Total equity attributable to owners of parent 5359648000
Non controlling interest 0
Total equity 5359648000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 164997000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities 164997000
Provisions, non-current 33599000
Deferred tax liabilities (net) -30000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 198566000
Current liabilities
Current financial liabilities
Borrowings, current 773833000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 61890000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 600656000
Total Trade payable 662546000
Other current financial liabilities
Total current financial liabilities 1436379000
Other current liabilities 253527000
Provisions, current 30085000
Current tax liabilities (Net) 62015000
Deferred government grants, Current
Total current liabilities 1782006000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1980572000
Total equity and liabilites 7340220000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Agrochemicals 380852000 1417224000
2 Active Pharma Ingredients (API) 5964000 64035000
3 Pharma Formulation 296129000 1625472000
4 Unallocated other operating revenue 0 0
Total Segment Revenue 682945000 3106731000
Less: Inter segment revenue 0 0
Revenue from operations 682945000 3106731000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Agrochemicals 76814000 286541000
2 Active Pharma Ingredients (API) -21363000 -89492000
3 Pharma Formulation 31402000 130361000
4 Unallocated other operating revenue 0 0
Total Profit before tax 86853000 327410000
i. Finance cost 28189000 28189000
ii. Other Unallocable Expenditure net off Unallocable income 0 0
Profit before tax 58664000 234074000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Agrochemicals 3195623000 3195623000
2 Active Pharma Ingredients (API) 1138503000 1138503000
3 Pharma Formulation 2940746000 2940746000
4 Unallocated other operating revenue 0 0
Total Segment Asset 7274872000 7274872000
Un-allocable Assets 0 0
Net Segment Asset 7274872000 7274872000
4 Segment Liabilities
Segment Liabilities
1 Agrochemicals 1097994000 1097994000
2 Active Pharma Ingredients (API) 41568000 41568000
3 Pharma Formulation 504606000 504606000
4 Unallocated other operating revenue 0 0
Total Segment Liabilities 1644168000 1644168000
Un-allocable Liabilities 0 0
Net Segment Liabilities 1644168000 1644168000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 234075000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 93337000
Adjustments for decrease (increase) in inventories -158735000
Adjustments for decrease (increase) in trade receivables, current -93740000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -69042000
Adjustments for decrease (increase) in other non-current assets -167717000
Adjustments for other financial assets, non-current 67771000
Adjustments for other financial assets, current 3051000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 140480000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -198857000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 157700000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 12961000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -212791000
Net cash flows from (used in) operations 21284000
Dividends received 0
Interest paid 0
Interest received -83067000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -14000000
Net cash flows from (used in) operating activities -75783000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 208313000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 83067000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities -125246000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 950000
Proceeds from issuing other equity instruments 135090000
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 81141000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 20495000
Interest paid 93337000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 103349000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -97680000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -97680000
Cash and cash equivalents cash flow statement at beginning of period 377375000
Cash and cash equivalents cash flow statement at end of period 279695000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s Rahul Chaudhary & Associates, Chartered Accountants Yes 30-Sep-2026